GSK To Make Trial Data Available To Researchers
GlaxoSmithKline PLC announced Thursday it would make data from clinical trials for its approved drugs and abandoned treatments available to the public, a move it classified as the first of its...To view the full article, register now.
Already a subscriber? Click here to view full article